Drug Search Results
More Filters [+]

Furosemide

Alternative Names: furosemide, frusemide, lasix, furosemid, fursemide, transit, salix, salinex, furix, scp-101, scp101, scp 101, furoscix, fuosemide, arroyo willow pollen, 10 tree mix, 11 tree pollen mix
Latest Update: 2024-11-05
Latest Update Note: Clinical Trial Update

Product Description

Furosemide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. urosemide is used alone or in combination with other medications to treat high blood pressure. Furosemide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease. (Sourced from: https://medlineplus.gov/druginfo/meds/a682858.html)

Mechanisms of Action: NKCC Inhibitor,TGFR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Heart Failure | Heart Failure, Acute | Heart Failure, Chronic | Liver Failure | Liver Failure, Acute | Pulmonary Edema | Edema

Known Adverse Events: Pain Unspecified | Erythema | Edema

Company: scPharmaceuticals
Company Location: BURLINGTON MA 01803
Company CEO: John H. Tucker
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Furosemide

Countries in Clinic: Australia, China, Czech Republic, Denmark, Germany, Spain, United States, Unknown Location

Active Clinical Trial Count: 12

Highest Development Phases

Phase 3: Heart Failure|Pain Unspecified

Phase 2: Adenocarcinoma|Dyspnea|Prostate Cancer

Phase 1: Gout|Healthy Volunteers|Malaria|Type 2 Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2024-510792-38-00

P3

Unknown Status

Pain Unspecified

2029-03-01

STUDY00004720

P2

Active, not recruiting

Adenocarcinoma|Prostate Cancer

2027-07-01

INFURO_2023

P2

Unknown Status

Dyspnea

2026-01-01

U1111-1302-1171

P1

Active, not recruiting

Healthy Volunteers

2024-11-08

Recent News Events